Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study
Jovan Julien, Turgay Ayer, Emily D. Bethea, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 6, pp. e316-e323
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 806
Global epidemiology of cirrhosis — aetiology, trends and predictions
Daniel Q. Huang, Norah A. Terrault, Frank Tacke, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 388-398
Open Access | Times Cited: 359
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Daniel Q. Huang, Amit G. Singal, Yuko Kono, et al.
Cell Metabolism (2022) Vol. 34, Iss. 7, pp. 969-977.e2
Open Access | Times Cited: 328
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 267
Noninvasive proteomic biomarkers for alcohol-related liver disease
Lili Niu, Maja Thiele, Philipp E. Geyer, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1277-1287
Open Access | Times Cited: 176
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Vy H. Nguyen, Michael H. Le, Ramsey Cheung, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 19, Iss. 10, pp. 2172-2181.e6
Closed Access | Times Cited: 172
Alcohol-associated liver disease
Bryan Mackowiak, Yaojie Fu, Luca Maccioni, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 93
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 92
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
Yuanbin Liu, Mingkai Chen
World Journal of Gastroenterology (2022) Vol. 28, Iss. 41, pp. 5910-5930
Open Access | Times Cited: 86
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 19
Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
Rebecca Wenling Zeng, Christen En Ya Ong, Elden Yen Hng Ong, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 12, pp. 2394-2402.e15
Closed Access | Times Cited: 15
Liver cirrhosis: Ancient disease, new challenge
Adrià Juanola, Elisa Pose, Pere Ginès
Medicina Clínica (English Edition) (2025)
Closed Access | Times Cited: 1
Effect of increased alcohol consumption during COVID‐19 pandemic on alcohol‐associated liver disease: A modeling study
Jovan Julien, Turgay Ayer, Elliot B. Tapper, et al.
Hepatology (2021) Vol. 75, Iss. 6, pp. 1480-1490
Open Access | Times Cited: 100
Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Haley Schoenberger, Nicolas Chong, David T. Fetzer, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 7, pp. 1561-1569.e4
Open Access | Times Cited: 83
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1931-1931
Open Access | Times Cited: 55
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease
Aritoshi Koizumi, Kosuke Kaji, Norihisa Nishimura, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3428-3446
Open Access | Times Cited: 13
Alcohol-related liver disease: A global perspective
Graciela Castro‐Narro, Luis Antonio Díaz, E. Ortega, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 5, pp. 101499-101499
Open Access | Times Cited: 10
Cirrhosis epidemiology in Denmark 1998–2022 and 2030 forecast
Linda Skibsted Kornerup, Frederik Kraglund, Gro Askgaard, et al.
JHEP Reports (2025), pp. 101353-101353
Closed Access | Times Cited: 1
Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
Abdel Aziz Shaheen, Kristine Kong, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 5, pp. e1170-e1179
Open Access | Times Cited: 41
Alcohol use disorder in community management of chronic liver diseases
Lorenzo Leggio, Jessica L. Mellinger
Hepatology (2022) Vol. 77, Iss. 3, pp. 1006-1021
Open Access | Times Cited: 31
Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): an open-label pragmatic feasibility randomised controlled trial
Mohsan Subhani, Doyo Gragn Enki, Holly Knight, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102069-102069
Open Access | Times Cited: 19
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis
Jeremy W. Luk, Derek D. Satre, Ramsey Cheung, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top